These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19891598)

  • 21. Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders.
    Ranieri R; Marasco D; Bifulco M; Malfitano AM
    Recent Pat CNS Drug Discov; 2016; 10(2):157-177. PubMed ID: 27184693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P2X7 antagonists for CNS indications: recent patent disclosures.
    Pevarello P; Bovolenta S; Tarroni P; Za L; Severi E; Torino D; Vitalone R
    Pharm Pat Anal; 2017 Mar; 6(2):61-76. PubMed ID: 28248151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological therapy of Parkinson's disease: current options and new avenues.
    Simola N; Pinna A; Fenu S
    Recent Pat CNS Drug Discov; 2010 Nov; 5(3):221-38. PubMed ID: 20726838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apoptosis: target for novel drugs.
    Alam JJ
    Trends Biotechnol; 2003 Nov; 21(11):479-83. PubMed ID: 14573360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockers of voltage-gated sodium channels for the treatment of central nervous system diseases.
    Tarnawa I; Bölcskei H; Kocsis P
    Recent Pat CNS Drug Discov; 2007 Jan; 2(1):57-78. PubMed ID: 18221218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel thyrotropin-releasing hormone analogs: a patent review.
    Khomane KS; Meena CL; Jain R; Bansal AK
    Expert Opin Ther Pat; 2011 Nov; 21(11):1673-91. PubMed ID: 22017410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent Trends in Nanotechnology Toward CNS Diseases: Lipid-Based Nanoparticles and Exosomes for Targeted Therapeutic Delivery.
    Cardoso AM; Guedes JR; Cardoso AL; Morais C; Cunha P; Viegas AT; Costa R; Jurado A; Pedroso de Lima MC
    Int Rev Neurobiol; 2016; 130():1-40. PubMed ID: 27678173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meningeal and choroid plexus cells--novel drug targets for CNS disorders.
    Dragunow M
    Brain Res; 2013 Mar; 1501():32-55. PubMed ID: 23328079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trace metal regulation of neuronal apoptosis: from genes to behavior.
    Levenson CW
    Physiol Behav; 2005 Oct; 86(3):399-406. PubMed ID: 16125208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
    Auxéméry Y
    Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The concept of microglia in relation to central nervous system disease and regeneration.
    Moore S; Thanos S
    Prog Neurobiol; 1996; 48(4-5):441-60. PubMed ID: 8804116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reorganization of the human central nervous system.
    Schalow G; Zäch GA
    Gen Physiol Biophys; 2000 Oct; 19 Suppl 1():11-240. PubMed ID: 11252267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opportunities in systems biology to discover mechanisms and repurpose drugs for CNS diseases.
    Mei H; Xia T; Feng G; Zhu J; Lin SM; Qiu Y
    Drug Discov Today; 2012 Nov; 17(21-22):1208-16. PubMed ID: 22750722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphodiesterase 10A inhibitors: a 2009 - 2012 patent update.
    Kehler J
    Expert Opin Ther Pat; 2013 Jan; 23(1):31-45. PubMed ID: 23210904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ubiquitin-proteasome pathway components as therapeutic targets for CNS maladies.
    Upadhya SC; Hegde AN
    Curr Pharm Des; 2005; 11(29):3807-28. PubMed ID: 16305513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotinic systems in central nervous systems disease: degenerative disorders and beyond.
    Newhouse PA; Kelton M
    Pharm Acta Helv; 2000 Mar; 74(2-3):91-101. PubMed ID: 10812945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system.
    Hughes PE; Alexi T; Walton M; Williams CE; Dragunow M; Clark RG; Gluckman PD
    Prog Neurobiol; 1999 Feb; 57(4):421-50. PubMed ID: 10080384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substituted cyclopentanes, tetrahydrofurans and pyrrolidines as orexin-1-receptor antagonists for treatment of various CNS disorders (WO2015/055994; WO2015/124932; WO2015/124934).
    Boss C; Roch C
    Expert Opin Ther Pat; 2016; 26(3):409-15. PubMed ID: 26593218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomedicine and its application in treatment of microglia-mediated neuroinflammation.
    Baby N; Patnala R; Ling EA; Dheen ST
    Curr Med Chem; 2014; 21(37):4215-26. PubMed ID: 25039775
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.